Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

US Patent 8470810 · Granted Jun 25, 2013

Estimated economic value: $15,222,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted imidazoquinolines2024
Substituted imidazoquinolines as agonists of TLR72024
Organic reactions carried out in aqueous solution in the presence of a hydroxyal2022
Substituted imidazoquinolines as agonists of TLR72022
Substituted imidazoquinolines2022
Organic reactions carried out in aqueous solution in the presence of a hydroxyal2020
Powdered adhesives2020
Fused heterocyclic compounds as S1P modulators2020
Foamed adhesive2019
Inhibitor compounds of phosphodiesterase type 10A2019
Quinoline compounds suitable for treating disorders that respond to the modulati2018
Quinoline compounds suitable for treating disorders that respond to the modulati2018